TrialThe New England journal of medicine2022
Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis.
Francesca Conradie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
317 papers cite itlatest 60 shown
this paperpooled ittrialcites it